Tumor Burden in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Head-to-Head Comparison of Current Scoring Systems
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor Burden in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Head-to-Head Comparison of Current Scoring Systems
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-02-23
DOI
10.3389/fonc.2022.850454
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Validation of the “Six-and-Twelve” Prognostic Score in Transarterial Chemoembolization–Treated Hepatocellular Carcinoma Patients
- (2021) Apichat Kaewdech et al. Clinical and Translational Gastroenterology
- Tumor burden score as a new prognostic marker for patients with hepatocellular carcinoma undergoing transarterial chemoembolization
- (2021) Shu‐Yein Ho et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Hepatic vein tumor thrombosis in patients with hepatocellular carcinoma: Prevalence and clinical significance
- (2021) Aline Mähringer‐Kunz et al. United European Gastroenterology Journal
- Redefining Tumor Burden in Patients with Intermediate-Stage Hepatocellular Carcinoma: The Seven-Eleven Criteria
- (2021) Ya-Wen Hung et al. Liver Cancer
- Immunonutritive Scoring in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Prognostic Nutritional Index or Controlling Nutritional Status Score?
- (2021) Lukas Müller et al. Frontiers in Oncology
- Expected outcomes and patients’ selection before chemoembolization—“Six-and-Twelve or Pre-TACE-Predict” scores may help clinicians: Real-life French cohorts results
- (2021) Xavier Adhoute et al. World Journal of Clinical Cases
- Relationships Between Indices of Tumor Aggressiveness in Hepatocellular Carcinoma
- (2021) Brian I. Carr et al. Journal of Gastrointestinal Cancer
- Hepatocellular carcinoma tumour burden score to stratify prognosis after resection
- (2020) D. I. Tsilimigras et al. BRITISH JOURNAL OF SURGERY
- Predicting survival after transarterial chemoembolization for hepatocellular carcinoma using a neural network: A Pilot Study
- (2020) Aline Mähringer‐Kunz et al. LIVER INTERNATIONAL
- Trans-arterial chemoembolization with degradable starch microspheres (DSM-TACE) versus selective internal radiation therapy (SIRT) in multifocal hepatocellular carcinoma
- (2020) Timo A Auer et al. ACTA RADIOLOGICA
- Response prediction of hepatocellular carcinoma undergoing transcatheter arterial chemoembolization: unlocking the potential of CT texture analysis through nested decision tree models
- (2020) Jan Vosshenrich et al. EUROPEAN RADIOLOGY
- Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: a multicentre observational study
- (2019) Qiuhe Wang et al. JOURNAL OF HEPATOLOGY
- A new ALBI‐based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma
- (2019) I‐Cheng Lee et al. LIVER INTERNATIONAL
- The “six-and-twelve score” for TACE treatment: Does it really help us?
- (2019) Marc Bourlière et al. JOURNAL OF HEPATOLOGY
- The Tumor Burden Score
- (2018) Kazunari Sasaki et al. ANNALS OF SURGERY
- Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study Group
- (2018) Alessandro Vitale et al. JOURNAL OF GASTROINTESTINAL SURGERY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- Extent of portal vein tumour thrombosis in patients with hepatocellular carcinoma: The more, the worse?
- (2018) Aline Mähringer-Kunz et al. LIVER INTERNATIONAL
- AASLD guidelines for the treatment of hepatocellular carcinoma
- (2017) Julie K. Heimbach et al. HEPATOLOGY
- New intermediate-stage subclassification for patients with hepatocellular carcinoma treated with transarterial chemoembolization
- (2017) Jin Hyoung Kim et al. LIVER INTERNATIONAL
- The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level
- (2017) et al. JAMA Oncology
- Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: a multi-center comparative study
- (2016) David J. Pinato et al. Oncotarget
- Hepatocellular carcinoma
- (2016) Josep M. Llovet et al. Nature Reviews Disease Primers
- Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
- (2015) Roman Kloeckner et al. BMC CANCER
- Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): The TRIPOD Statement
- (2015) G. S. Collins et al. CIRCULATION
- Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
- (2015) Philip J. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Addition of tumor multiplicity improves the prognostic performance of the hepatoma arterial-embolization prognostic score
- (2015) Yehyun Park et al. LIVER INTERNATIONAL
- Risk prediction for patients with hepatocellular carcinoma undergoing chemoembolization: development of a prediction model
- (2015) Beom Kyung Kim et al. LIVER INTERNATIONAL
- Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
- (2014) R Golfieri et al. BRITISH JOURNAL OF CANCER
- How to STATE suitability and START transarterial chemoembolization in patients with intermediate stage hepatocellular carcinoma
- (2014) Florian Hucke et al. JOURNAL OF HEPATOLOGY
- A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer
- (2013) L. Kadalayil et al. ANNALS OF ONCOLOGY
- Heterogeneity of Patients with Intermediate (BCLC B) Hepatocellular Carcinoma: Proposal for a Subclassification to Facilitate Treatment Decisions
- (2013) Andrew Burroughs et al. SEMINARS IN LIVER DISEASE
- Transcatheter Treatment of Hepatocellular Carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): Technical Recommendations
- (2011) Riccardo Lencioni et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Conventional versus Doxorubicin-eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma
- (2011) Rodolfo Sacco et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data
- (2011) Hajime Uno et al. STATISTICS IN MEDICINE
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
- (2009) Johannes Lammer et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
- (2008) Vincenzo Mazzaferro et al. LANCET ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started